Neurocrine Biosciences reported $9.08B in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 190.63B 8.32B
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Acorda Therapeutics ACOR:US $ 51.17M 5.91M
Adamas Pharmaceuticals ADMS:US 223.88M 15.88M
Agios Pharmaceuticals AGIO:US $ 2.72B 672.75M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amgen AMGN:US $ 120.75B 19.29B
Aptinyx Inc APTX:US $ 158.45M 34.48M
Biogen BIIB:US $ 42.17B 9.96B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Cytokinetics CYTK:US $ 2.98B 1.57B
Dynavax Technologies DVAX:US $ 2.2B 1.08B
Enanta Pharmaceuticals ENTA:US $ 1.15B 259.62M
Exelixis EXEL:US $ 6.66B 950.22M
Gilead Sciences GILD:US $ 87.58B 1.22B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Halozyme Therapeutics HALO:US $ 5.79B 675.56M
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
Intra Cellular Therapies ITCI:US $ 3.03B 286.74M
Nektar Therapeutics NKTR:US $ 3.3B 172.65M
Neurocrine Biosciences NBIX:US $ 9.08B 123.68M
Pfizer PFE:US $ 241143.67M 21937.97M
Prothena PRTA:US 3.21B 937.65M
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Repligen RGEN:US $ 15.89B 4.93B
Rigel Pharmaceuticals RIGL:US $ 620.19M 118.33M
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Teva Pharmaceutical TEVA:IT 34.99B 801.25M
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M
Vertex Pharmaceuticals VRTX:US $ 47.06B 5.14B
Xoma XOMA:US $ 279.95M 104.59M
YTE INCY:US $ 15.19B 3.31B
Zogenix ZGNX:US $ 849.09M 115.36M